EVENTS:   Best Equity Short Ideas Conference Call 12 - Zach Shannon/Corto Capital Advisors & Craig Huber/Huber Research Partners & Thomas Beevers /Forensic Alpha & Ed Steele/Iron Blue Financials & Bill Campbell/Paragon Intel - 12 Nov 25   Will AI Deflate the World? Macro Lessons from Three Industrial Revolutions and China - Manoj Pradhan/Talking Heads Macro - 13 Nov 25     ROADSHOWS: Forest Products Sector Equity and Commodity Research With Expertise in Distressed Debt - Kevin Mason /ERA Research   •   London   12 - 14 Nov 25       Buyside to Buyside Forum and Expert Calls across TMT, Consumer, Healthcare and Fintech - Andrew Peters /Revelare Partners   •   London   17 - 19 Nov 25       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   17 - 19 Nov 25      

Equity Investing into the Abyss

Boyar Research

Fri 03 Apr 2020 - 14:00

Summary

Since its founding in 1975 Boyar Research has been through many crisis. While they all had different characteristics, the Boyar approach to investment has remained consistent, and that is finding companies trading below their intrinsic worth. That said, Jon pointed out that if one bought the most adversely affected stocks after 9/11 (that could weather the storm), such as cruise operators, hotels, travel and leisure related stocks like Disney, you would have outperformed the S&P 500 as they bounced back strongly. A contrarian approach pays and this is a position Boyar Research aim to occupy. Not for contrarians sake, they find intrinsically undervalued companies but with a catalyst. Jon highlighted a selection of companies that fit this criteria and are investable currently. MSG, a hidden-asset play. eBay, spin-off and activism. Starbucks, growth potential. Mohawk, out of favour duopoly. Cisco, transforming business model. Liberty Braves, owners of a trophy asset.

Topics

Equity investing in a crisis with a focus on Value stocks:

Cisco, Bank of America, DuPont, Liberty Braves, MSG Networks, Mohawk, JetBlue, Watsco, eBay, IAC, CVS Health